NCT00835692View on ClinicalTrials.gov

Clarithromycin 500 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Healthy
Interventions
DRUG

Clarithromycin

500 mg Tablet

DRUG

Biaxin®

500 mg Tablet

Trial Locations (2)

56721

PRACS Institute Ltd, East Grand Forks

58104

PRACS Institute Ltd, Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835692 - Clarithromycin 500 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter